Research Resources

Updates in Movement Disorders: From Regional Challenges to Global Standards

Live Online

Jul 18, 2025 - Jul 19, 2025

Experienced / Intermediate, Foundational / Beginner

987<p>This course addresses the global practice gap in the diagnosis and management of Parkinson&rsquo;s disease and other movement disorders, with the aim to equip healthcare professionals with the latest evidence-based approaches to improve early diagnosis, treatment precision, and patient outcomes.</p><p><strong>REGISTRATION DEADLINE</strong>: July 16, 2025<strong></strong></p>4800.00https://education.movementdisorders.org/Detail/987/MDS-AOS-Updates-in-Movement-Disorders:-From-Regional-Challenges-to-Global-Standardshttps://education.movementdisorders.org/Upload/ActivityImages/25AOSMD_202x108488497.jpghttps://education.movementdisorders.org/Upload/BannerImages/25AOSMD_783x404462294.jpg2025-07-18T00:00:002025-07-19T00:00:00<p><br></p><p><br></p>MDS Education<p><!--[if !vml]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/UPDATED_25AOSMD%20Course%20Agenda_20062025100904.pdf"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1747231616006_14052025090655.png" class="fr-fic fr-dii"></a><!--[endif]--><strong>Course Schedule&nbsp;</strong><strong>&nbsp;</strong><!--[if !vml]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/3.%20Faculty%20Listing%20(w%20Photos)%20UPDATED_20062025101551.pdf"><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1747231616039_14052025090656.png" class="fr-fic fr-dii"></a><!--[endif]--><strong>Course Faculty</strong><strong>&nbsp;</strong></p><p><br></p><p><em>Schedule as of June 18, 2025 <br></em></p><p><strong><em>Registration&nbsp;</em></strong><em><strong>Deadline:</strong></em><em><strong>&nbsp;</strong></em>July 16<em>, 2025</em></p><p><br></p><p><strong>REGISTRATION FEES</strong></p><p><strong>Members:</strong> Free<br><strong>Non-Members*:</strong>&nbsp;$25 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><br></p><p><strong>July 18-</strong><strong>19, 2025</strong><em><br></em>Day 1: Parkinson&rsquo;s Disease &ndash; New Horizons</p><p><em>Friday, July 18, 2025: 13:00 &ndash; &nbsp;17:10 (UTC)</em></p><p>Day 2: Broadening the Scope &ndash; Other Movement Disorders</p><p><em>Saturday, July 19, 2025: 13:00 &ndash; 17:10 (UTC)</em></p><p><br></p><p><em>To convert to your local time, please click here:&nbsp;</em><a href="https://www.timeanddate.com/worldclock/converter.html"><em>https://www.timeanddate.com/worldclock/converter.html</em></a><em>&nbsp;&nbsp;</em>&nbsp;</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Describe key advances in the biological classification, genetic diagnostics, and emerging therapies for Parkinson&rsquo;s disease.</p><p>2. Evaluate the current and future roles of deep brain stimulation (DBS), including closed-loop systems and other neuromodulation strategies.</p><p>3. Interpret the utility of biomarkers in diagnosing and tracking progression of movement disorders.</p><p>4. Summarize evolving treatment approaches for other major movement disorders, including Huntington&rsquo;s disease, PSP, dystonia, and essential tremor.</p><p>5. Critically assess innovative and emerging interventions, such as stem cell therapies and neurorehabilitation.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, researchers, clinical fellows, medical residents, medical students, allied health professionals with an interest in current clinical trends and approaches for diagnosis and treatment of movement disorders.</p>0/Courses/Updates-in-Movement-Disorders-From-Regional-Challenges-to-Global-Standards.htmUpdates in Movement Disorders: From Regional Challenges to Global Standards2025-05-29T18:01:04.90000Experienced / IntermediateFoundational / BeginnerLive OnlineBiomarkersBotulinum toxinClinical TrialsDeep brain stimulationDopaminergic medicationsFocused UltrasoundGene TherapiesGeneticsInfusion therapyMedications for motor complicationsMedications for motor symptomsMedications for non-motor symptomsNeuroimagingNeuropathologyNon-invasive stimulationRating Scales

Journal CME 40.05: Artificial Intelligence-Based Virtual Assistant for the Diagnostic Approach of Chronic Ataxias

On Demand

60 Minutes

Foundational / Beginner

992<p>The Journal CME 40.05 article aims to develop and validate an AI powered virtual assistant for diagnosing chronic ataxias.</p>Lucas Alessandro, MD601.002025-05-21https://education.movementdisorders.org/Detail/992/Journal-CME-40-05:-Artificial-Intelligence-Based-Virtual-Assistant-for-the-Diagnostic-Approach-of-Chronic-Ataxiashttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-05-21T00:00:002026-05-21T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.05%20-%20Disclosures_20052025015905.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong><br>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.<br><br><strong>LEARNING OBJECTIVES</strong><br>Upon completion of this activity, learners will be able to:<br>1. Understand the diagnostic challenges associated with chronic ataxias due to their clinical and genetic heterogeneity<br>2. Assess how AI can improve diagnostic accuracy and efficiency for chronic ataxias<br>3. Evaluate the performance of the AI-based virtual assistant in diagnosing chronic ataxias<br><br><strong>INTENDED AUDIENCE</strong><br>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.<br><br><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong><br>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.<br>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).<br>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.<br>4. Adobe Flash Player 12.0 (or higher).<br>5. Adobe Reader to print certificate.<br><br><br></p>0/Courses/Journal-CME-40.05-Artificial-Intelligence-Based-Virtual-Assistant-for-the-Diagnostic-Approach-of-Chronic-Ataxias.htmJournal CME 40.05: Artificial Intelligence-Based Virtual Assistant for the Diagnostic Approach of Chronic AtaxiasJournal CME 40.052025-05-27T18:00:56.42300Foundational / BeginnerOn-DemandAtaxiasBiomarkersGeneticsNeuroimagingRating Scales

Advances in Technology and Artificial Intelligence Applications in Movement Disorders

In-Person

Madrid

Dec 12, 2025 - Dec 13, 2025

Experienced / Intermediate

990<p>MDS-ES Advances in Technology and Artificial Intelligence Applications in Movement Disorders delves into crucial aspects of the paradigm shift associated with AI and new technologies in clinical practice and their future challenges. This course will include different topics the application of AI and new technologies in clinical practice, research and teaching, engaging the audience in a comprehensive exploration of the multifaceted dimensions of these tools. Equally important aspects such as ethics and legal aspects of including AI and new technologies in clinical practice will also be covered.<strong></strong><strong></strong></p>7200.000001-01-01https://education.movementdisorders.org/Detail/990/MDS-ES-Advances-in-Technology-and-Artificial-Intelligence-Applications-in-Movement-Disordershttps://education.movementdisorders.org/Upload/ActivityImages/25ESMD-Tech&AI_202x108552742.jpghttps://education.movementdisorders.org/Upload/BannerImages/25ESMD-Tech&AI_734x404890566.jpg2025-12-12T00:00:002025-12-13T00:00:00Madrid<p><br></p><p><br></p>MDS Education<p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/25ESMD%20-%20Course%20Agenda%20TO%20POST%20(w.o%20Faculty)_20052025101825.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1738175528174_29012025123206.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/25ESMD%20-%20Course%20Agenda%20TO%20POST%20(w.o%20Faculty)_20052025101825.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong><strong>&nbsp;</strong></a><a href="https://form.jotform.com/251355203543146" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1738175528255_29012025123207.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://form.jotform.com/251355203543146" rel="noopener noreferrer" target="_blank"><strong>Travel Grant</strong></a><strong>&nbsp;</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing%20(CD)_29042025091726.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1738175528216_29012025123207.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing%20(CD)_29042025091726.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of May 20, 2025</em></p><p><strong><em>Application Deadline:&nbsp;</em></strong><em>&nbsp;July 10, 2025</em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong>&nbsp; $275 USD<br><strong>Members</strong><strong>: Junior / HP / Basic Science / No Fee:</strong>&nbsp;$250 USD<br><strong>Non-Members*:</strong>&nbsp;$325 USD<br><br></p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em><br><br></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf" rel="noopener noreferrer" target="_blank">Click here to view the MDS&nbsp;Regional Course Cancellation Policy &amp; Visa Assistance Information</a></p><p><br></p><p><strong>COURSE VENUE</strong></p><p>Venue Name: Vincci Soma Hotel, Madrid, Spain.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Identify the current status and future landscapes of Artificial Intelligence and New Technologies<br>2. Relate the benefits and goals of application of Artificial Intelligence and New Technologies in patient-centered outcomes<br>3. Integration of Artificial Intelligence in the diagnosis, advanced therapies, HIFU and DBS teleprogramming in Parkinson&acute;s disease.<br>4. Relate the ethics and legal aspects of integrating Artificial Intelligence and New Technologies in clinical practice</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, fellows, and translational researchers and biomedical engineers.</p>Madrid0/Courses/Advances-in-Technology-and-Artificial-Intelligence-Applications-in-Movement-Disorders.htmAdvances in Technology and Artificial Intelligence Applications in Movement Disorders2025-05-20T18:00:55.53300Experienced / IntermediateIn-PersonBiomarkersChorea/Huntingtons Disease (HD)Clinical TrialsCorticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD)Deep brain stimulationDystoniaFocused UltrasoundFreezing of Gait (FOG)Gene TherapiesGeneticsInfusion therapyLewy-body dementia (LBD)Multiple Systems Atrophy (MSA)MyoclonusNeuroimagingNeuropathologyParkinson's Disease (PD)Progressive Supranuclear Palsy (PSP)Rating ScalesTics/Tourettes syndrome (TS)Tremor/Essential Tremor (ET)

Journal CME 40.04: Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson’s Disease

On Demand

60 Minutes

Experienced / Intermediate, Foundational / Beginner

979<p>The Journal CME 40.04 article aims to unravel the pathological relationship between human endogenous retrovirus K (HERV-K) and PD, determine the localization of HERV-K in the brain, determine whether HERV-K levels are altered in PD brain and blood, and examine whether HERV-K could serve as a biomarker for PD.</p>YuHong Fu, PhD601.002025-05-05https://education.movementdisorders.org/Detail/979/Journal-CME-40-04:-Human-Endogenous-Retrovirus-K-in-Astrocytes-Is-Altered-in-Parkinson’s-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-05-05T00:00:002026-05-05T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.04%20-%20Disclosures_02052025032439.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the potential pathological role of HERV-K in Parkinson&rsquo;s disease (PD)</p><p>2. Identify the localization of HERV-K expression in the brain in relation to PD</p><p>3. Evaluate the potential of HERV-K as a biomarker through its expression levels in PD brain and blood</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.04-Human-Endogenous-Retrovirus-K-in-Astrocytes-Is-Altered-in-Parkinsons-Disease.htmJournal CME 40.04: Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson’s DiseaseJournal CME 40.042025-05-05T09:01:00.80300Experienced / IntermediateFoundational / BeginnerOn-DemandBiomarkersGeneticsNeuropathologyParkinson's Disease (PD)